Kolumne, ORE

Original-Research: beaconsmind AG - from NuWays AG Classification of NuWays AG to beaconsmind AG Company Name: beaconsmind AG ISIN: CH0451123589 Reason for the research: Update Recommendation: Buy from: 28.02.2024 Target price: 15.00 Target price on sight of: 12 Monaten Last rating change: Analyst: Philipp Sennewald Strong order intake to start the year; chg.

28.02.2024 - 09:06:31

Original-Research: beaconsmind AG (von NuWays AG): Buy


Original-Research: beaconsmind AG - from NuWays AG

Classification of NuWays AG to beaconsmind AG

Company Name: beaconsmind AG
ISIN: CH0451123589

Reason for the research: Update
Recommendation: Buy
from: 28.02.2024
Target price: 15.00
Target price on sight of: 12 Monaten
Last rating change: 
Analyst: Philipp Sennewald

Strong order intake to start the year; chg.
 
Topic: beaconsmind announced three major contract extensions, two of which
in the CloudWiFi hotspot segment, proving the strength of the groups newly
aligned product portfolio. In detail:
 
The company extended its collaboration with nursing homes operator Vitanas,
where beaconsmind will implement comprehensive Wi-Fi coverage at 15
additional locations. The project is scheduled to be rolled out in Q2 '24
and has a total sales volume of c. CHF 1m. In addition, the company also
expanded its contract with retail company Müller. After beaconsmind
implemented its Wi-Fi solutions in over 770 stores in the DACH region and
Spain in recent year, the company was now commissioned to install FREDERIX
CloudWiFi also in the remaing c. 145 stores in CEE. The project rollout is
scheduled for the first half of 2024 and should generate total sales in the
lower single-digit CHFm range (eNuW). With this, beaconsmind is once again
proving the compelling up- and cross-selling potential of the product
portfolio as well as the value-added from the recent acquisitions. On top
of this, beaconsmind gained property manager Reos GmbH as a customer, as
the company will roll-out a self-developed VPN network across all ten
locations of Reos. The deal is announced to have a total volume of c. CHF
0.5m.
 
Impact of transaction to unfold in H2. beaconsmind is seen to report a
solid set of FY figures in May, which are seen to display the full effect
of the recent acquisitions. In detail, we expect sales to come in at CHF
6.9m (H2: CHF 4.3m) and an EBITDA of CHF -0.6m (H2: CHF -0.1m). In FY '24e
sales are seen to increase to CHF 12.5m, which is in line with managements
guidance of CHF 12.6m, while EBITDA looks set to turn positive at CHF 2m.
The main drivers for this should be (1) the full effect of the acquisitions
of KADSOFT and T2 (closed in H2 '23), (2) synergy effects from crossselling
across the beaconsomind Group enhancing organic growth, (3) the ongoing
internationalization as well as (3) the continuously growing share of SaaS
revenues (see p. 2) allowing for improved operating leverage.
 
Mind you, the company looks set to continue its Buy & Build strategy (5
acquisitions in past 18 months) going forward. For 2024e, we expect
acqusitions to the tune of EUR 4-5m sales to be in the pipeline. Here,
management is seen to be looking for margin accretive, bolt-on acqusitions.
As future M&A is not included in our model, this leaves a certain upside to
our estimates.
 
Reiterate BUY with a new PT of EUR 15.00 based on DCF.

You can download the research here:
http://www.more-ir.de/d/28999.pdf
For additional information visit our website
www.nuways-ag.com/research.

Contact for questions
Die Analyse oder weiterführende Informationen zu dieser können Sie hier downloaden
www.nuways-ag.com/research.
Kontakt für Rückfragen
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse.
++++++++++

-------------------transmitted by EQS Group AG.-------------------


The issuer is solely responsible for the content of this research.
The result of this research does not constitute investment advice
or an invitation to conclude certain stock exchange transactions.

@ dpa.de

Weitere Meldungen

Original-Research: Nynomic AG (von Montega AG): Kaufen Original-Research: Nynomic AG - von Montega AG Einstufung von Montega AG zu Nynomic AG Unternehmen: Nynomic AG ISIN: DE000A0MSN11 Anlass der Studie: Update Empfehlung: Kaufen seit: 10.05.2024 Kursziel: 47,00 EUR (zuvor: 48,00 EUR) Kursziel auf Sicht von: 12 Monaten Letzte Ratingänderung: - Analyst: Miguel Lago Mascato Q1: Solider Jahresauftakt - Steigerung der ausgezeichneten H2/23-Performance & M&A-Newsflow erwartet Nynomic hat Mittwoch Q1-Zahlen veröffentlicht, die eine spürbare Steigerung ggü. (Boerse, 10.05.2024 - 16:16) weiterlesen...

Original-Research: MPH Health Care AG (von First Berlin Equity Research GmbH)... Original-Research: MPH Health Care AG - from First Berlin Equity Research GmbH Classification of First Berlin Equity Research GmbH to MPH Health Care AG Company Name: MPH Health Care AG ISIN: DE000A289V03 Reason for the research: Vorläufige Ergebnisse 2023 Recommendation: Kaufen from: 10.05.2024 Target price: EUR81 Target price on sight of: 12 Monate Last rating change: - Analyst: Ellis Acklin First Berlin Equity Research hat ein Research Update zu MPH Health Care AG (ISIN: DE000A289V03) veröffentlicht. (Boerse, 10.05.2024 - 12:41) weiterlesen...

Original-Research: Knaus Tabbert AG (von First Berlin Equity Research GmbH): ... Original-Research: Knaus Tabbert AG - from First Berlin Equity Research GmbH Classification of First Berlin Equity Research GmbH to Knaus Tabbert AG Company Name: Knaus Tabbert AG ISIN: DE000A2YN504 Reason for the research: Dreimonatsbericht Recommendation: Kaufen from: 10.05.2024 Target price: EUR86 Target price on sight of: 12 Monate Last rating change: - Analyst: Ellis Acklin First Berlin Equity Research hat ein Research Update zu Knaus Tabbert AG (ISIN: DE000A2YN504) veröffentlicht. (Boerse, 10.05.2024 - 11:46) weiterlesen...

Original-Research: ZEAL Network SE (von NuWays AG): Kaufen Original-Research: ZEAL Network SE - from NuWays AG Classification of NuWays AG to ZEAL Network SE Company Name: ZEAL Network SE ISIN: DE000ZEAL241 Reason for the research: Recommendation: Kaufen from: 10.05.2024 Target price: EUR 53.00 Target price on sight of: 12 Monaten Last rating change: Analyst: Henry Wendisch Staggering Q1 kicks off new growth phase; chg est. (Boerse, 10.05.2024 - 09:07) weiterlesen...

Original-Research: Nynomic AG (von NuWays AG): Kaufen Original-Research: Nynomic AG - from NuWays AG Classification of NuWays AG to Nynomic AG Company Name: Nynomic AG ISIN: DE000A0MSN11 Reason for the research: Update Recommendation: Kaufen from: 10.05.2024 Target price: EUR 52.00 Target price on sight of: 12 Monaten Last rating change: Analyst: Christian Sandherr Solid start into FY24 despite challenging end markets Topic: Nynomic published a solid start into the year with order intake returning to growth for the first time since Q3 2022. (Boerse, 10.05.2024 - 09:06) weiterlesen...

Original-Research: R. STAHL AG (von NuWays AG): Kaufen. STAHL AG - from NuWays AG Classification of NuWays AG to R. Original-Research: R. (Boerse, 10.05.2024 - 09:02) weiterlesen...